by In some parts of the country, a terminal prostate cancer is diagnosed in some parts of the country almost twice as often as in others, as can result in telegraph.
According to the first study, the patients in Devon and Cornwall fell to examine the geographical variation of such details.
Those in London had the best chance, the lowest number of cases being diagnosed if the disease spread beyond the prostate beyond the prostate, together with Kent and Medway, Dorset, Hampshire and the Isle of Wight.
Areas with higher rates of advanced cases had fewer diagnoses of prostate cancer. Experts said that the chances of survival were far too dependent on whether the men were offered a prostate-specific blood test (PSA).
Health Minister Wes Streeting said that the results were “deeply worrying” and “emphasize unacceptable inequalities in our health system”.
The Telegraph is committed to the introduction of targeted screening. Therefore, most endangered how black men and people with a family history are offered PSA tests.
Mr. Streeting said: “We examine the introduction of targeted screening, but every decision must be directed.
“That is why the British National Screening Committee sees this as a priority – including reviewing the evidence of the screening of men with a family history of prostate cancer.”
Charity organization Prostate Cancer UK said that the results of the National Prostate Cancer Audit contribute to a “mountain of evidence” that too many men receive an unfair deal.
According to the current system, men can ask GPS for tests, but many refuse to the under 50 years and general practitioners are said that they should not offer the tests proactively.
The late diagnosis is associated with far worse survival. Men who diagnosed early prostate cancer have a five -year survival rate of almost 100 percent. This is compared to around 50 percent as soon as they have spread beyond the prostate.
Every year around 55,000 men are diagnosed with prostate cancer, which makes it the most common cancer in men with 12,000 deaths.
However, prostate cancer is the only big cancer without screening program.
The British National Screening Committee (UKNSC) is currently considering whether the introduction of tests is recommended.
In the past, the idea refused because the concern that PSA tests are too unreliable and would lead to too many men being carried out unnecessary procedures.
In recent years, the backup technology, which has been used to confirm a diagnosis, has significantly improved, whereby the hope that further progress in the transformation of prostate Cancer UK will be tested in the Trands study that the screening could reduce deaths by 40 percent in the future.
The study published in the BMJ oncology analyzed over 212,000 cases that were diagnosed in England between 2015 and 2019, using the English National Cancer Registration Dataset held by the NHS.
There was significant regional variations of the rates of metastatic prostate cancer in diagnosis in 21 areas.
In Devon, Cornwall and the Isles of Scilly there were 6.84 cases in the metastatic stage per 10,000 inhabitants, compared to 4.02 in the north central London.
The researchers said that the differences were probably driven by variation of the use of PSA tests with differences between GPS and areas in the probability of execution tests.
Prostate Cancer UK presented evidence at the UKNSC almost three years ago and made himself the highest risk of acquiring prostate cancer for targeted screening for men, which includes black men and men with a family history of the disease.
Chiara de Biase, the director of health services, equity and improvement in the charity, said: “This research shows that her postcode is currently largely prescribed in Great Britain whether you receive or not incurable prostate cancer diagnosis.
“At Prostate Cancer UK, we will not accept this deteriorating situation – we are fighting to make the system fairer everywhere for men.”
The charity also calls on the government to take immediate measures in order to revise existing NHS guidelines so that the GPS is encouraged to address the problem of prostate cancer in patients.
Ms. de Biase said: “The current NHS guidelines are confusing and outdated and prevents GPS from increasing the problem of prostate cancer in patients.
“Prostate Cancer UK calls for a simple, free change in these guidelines and enables the GPS to proactively start discussions with men with men who have the highest risk of prostate cancer.
“It is time for the government to take this logical action to give men across Great Britain a fairer shot on a curable diagnosis.”
Researcher Professor Jan van der Meulen, clinical epidemiologist of the London School of Hygiene & Tropical Medicine, called for a revision of existing methods to recognize diseases.
He said: “We are calling on the review of the national recommendations for prostate cancer screening and building on the quick clinical advances in prostate imaging, blood and saliva-based tests, biopsy techniques, surgical and oncological treatments and aftercare that increase the potential damage of a formal screing program reduce.”
